SCHEMBL18470164

SCHEMBL18470164

CCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)NC3=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 7/20 0.51
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ RGS12 O14924 2/20 0.47
▸ HTT P42858 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PABPC1 P11940 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ STAT3 P40763 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ PIN1 Q13526 1/20 0.42
▸ PIN4 Q9Y237 1/20 0.42
▸ USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470165 0.88 MEN1 (0.56) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL17775320 0.87 TERT (0.56) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL14823392 0.87 MEN1 (0.54) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL6344071 0.85 CYP1B1 (0.55) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL18470149 0.82 KDM4E (0.61) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL8680446 0.81 TERT (0.67) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL21081429 0.81 TERT (0.61) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL12565564 0.81 MEN1 (0.49) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL18470159 0.80 KDM4E (0.62) TERTMEN1KMT2ARAB9ARGS12
SCHEMBL28628646 0.79 TERT (0.82) TERTMEN1KMT2ARAB9ARGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098996-A1 IMPROVED ELECTRODE MATERIAL FOR PRINTING ORGANIC POLYMER BATTERIES EVONIK OPERATIONS GMBH (DE) 2023-06-08 — — WO disclosed
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETEN SCHAPPELIJK ONDERZOEK TNO (NL) 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS ANTXR2, CLPP, DAD1 TERT 4843/4885MEN1 4740/4885KMT2A 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback